/
/
Parkinson’s UK

Parkinson’s UK

What is funded:

  • to better understand the causes of Parkinson’s and Parkinson’s like disorders
  • to investigate the potential links between diabetes and Parkinson’s
  • drug discovery at all stages of the drug discovery pipeline
  • cohort studies
  • early clinical investigations looking at biomarkers
  • pilot clinical trials
  • areas of unmet needs

Eligibility:

Co-applicants and collaborators may be based at institutions outside the UK or at pharmaceutical or biotech companies. Grants are tenable only at a UK university, NHS Trust, statutory social care organisation or other UK research institution.

Deadline:

  • Preproposal: January 7th 2026 4pm
  • Full application deadline: April 8th 2026

The duration of a grant is up to a maximum of 36 months.

There is no fixed minimum or maximum value for project grants.

The cost of applications is usually up to £400,000 and the average amount awarded is £260,000.

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

Latest Updates

Senza titolo

We are thrilled to share a new impactful scientific publication that contributes significantly to the field of immune profiling and translational immunology. The article, titled...

IMG_3148 (1)

From 12 to 14 June 2026, the IMMUPARKNET community gathered in the historic city of Coimbra, Portugal, for the Final Annual Conference of COST Action...

wpc2026_logo

IMMUPARKNET, the leading network dedicated to researching the role of immunity and neuroinflammation in Parkinson’s Disease, proudly announces the participation of its prominent members at...

IMG_1591

For more than 20 years, the Dopamine Meetings have provided a collaborative forum for scientists from diverse backgrounds to share their latest work and ideas....

ChatGPT Image 27 mag 2026, 10_24_30

📍 Faculty of Medicine, University of Coimbra (FMUC), Portugal📅 12–14 June 2026 We are pleased to present the final program of the 4th and final...

Seville, 9–10 April 2026 The second edition of the IMMUPARKNET Training School was held at the Instituto de Biomedicina de Sevilla (IBiS) in Seville, Spain,...